Report: Evaluating the ability of the TMA Clinical Decision Support platform to identify interventions in a clinical setting
Keywords:
TMA, platform in identifying, clinical settingAbstract
The TMA Precision Health Clinical Decision Support system is a commercially available software platform focused on the confirmation of a precision diagnosis and generation of a personalized care plan to rapidly deliver therapeutic optionality and improve quality of life for rare and complex disease patients. For this study, we worked with our partners in Medellin, Colombia to evaluate the efficacy of the platform in identifying previously unexplored modes of care within a small sample population of adult patients suffering from a diverse set of rare diseases. Although challenges were encountered during the curation of data from multiple sources, personalized care plans and medication options were identified successfully for 94% of cases, suggesting a high level of impact for deployment at scale.
Downloads
References
Nguengang Wakap, S., Lambert, D.M., Olry, A. et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet 28, 165–173 (2020). https://doi.org/10.1038/s41431-019-0508-0
Laura Joszt, MA. Not So Rare: 300 Million People Worldwide Affected by Rare Diseases, AJMC https://www.ajmc.com/view/not-so-rare-300-million-people-worldwide-affected-by-rare-diseases
Ramalle-Gómara, E., Domínguez-Garrido, E., Gómez-Eguílaz, M. et al. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis 15, 18 (2020). https://doi.org/10.1186/s13023-019-1285-0
Karolina Budych, Thomas M. Helms, Carsten Schultz, How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient–physician interaction, Health Policy, Volume 105, Issues 2–3,2012,Pages 154-164,ISSN 0168-8510, https://doi.org/10.1016/j.healthpol.2012.02.018.
Vandeborne, L., van Overbeeke, E., Dooms, M. et al. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis 14, 99 (2019). https://doi.org/10.1186/s13023-019-1075-8
Knight and Senior. The common problem of rare disease in general practice. Med Jour of Australia, Vol 185 Number 2, July 2006 https://www.mja.com.au/system/files/issues/185_02_170706/kni10328_fm.pdf
Østbye, T., Yarnall, K. S., Krause, K. M., Pollak, K. I., Gradison, M., & Michener, J. L. (2005). Is there time for management of patients with chronic diseases in primary care? Annals of family medicine, 3(3), 209–214. https://doi.org/10.1370/afm.310
Dong, D., Chung, R.YN., Chan, R.H.W. et al. Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China. Orphanet J Rare Dis 15, 307 (2020). https://doi.org/10.1186/s13023-020-01587-2
Joseph A. Kitterman, Sharon Kantanie, David M. Rocke and Frederick S. Kaplan Pediatrics November 2005, 116 (5) e654-e661; DOI: https://doi.org/10.1542/peds.2005-0469
Makary, Martin & Daniel, Michael. (2016). Medical Error-the Third Leading Cause of Death in the US. BMJ. 353. i2139. 10.1136/bmj. i2139.
Thaib, P. K. P., & Rahaju, A. S. (2022). Clinicopathological profile of clear cell renal cell carcinoma. International Journal of Health & Medical Sciences, 5(1), 91-100. https://doi.org/10.21744/ijhms.v5n1.1846
Sutton, R.T., Pincock, D., Baumgart, D.C. et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. npj Digit. Med. 3, 17 (2020). https://doi.org/10.1038/s41746-020-0221-y
Halevy A, Lessons from oncology drive precision medicine across clinical specialties. The Journal of Precision Medicine https://www.thejournalofprecisionmedicine.com/the-journal-of-precision-medicine/lessons-from-oncology-drive-precision-medicine-across-clinical-specialties/
Evans, W. R., & Rafi, I. (2016). Rare diseases in general practice: recognising the zebras among the horses. The British journal of general practice: the journal of the Royal College of General Practitioners, 66(652), 550–551. https://doi.org/10.3399/bjgp16X687625
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
The National Economic Burden of Rare Disease Study. Feb 2021 https://everylifefoundation.org/wp-content/uploads/2021/02/The_National_Economic_Burden_of_Rare_Disease_Study_Summary_Report_February_2021.pdf?eType=EmailBlastContent&eId=1d1fcfbd-10fc-4553-bf38-dfd73c7e7cd8
How to Find a Disease Specialist https://rarediseases.info.nih.gov/guides/pages/25/how-to-find-a-disease-specialist
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
